Xingxu Huang

Dr. Xingxu Huang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2017 in eLife
Verified
Journal Article
Open access
IRIan A Roundtree
Ian A Roundtree
GLGuanzheng Luo
Guanzheng Luo
ZZZijie Zhang
Zijie Zhang
XWXiao Wang
Xiao Wang
TZTao Zhou
Tao Zhou
CHChuan He
Chuan He
N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic messenger RNA (mRNA) and plays critical roles in RNA biology. The function of this modification is mediated by m6A-selective ‘reader’ proteins of the YTH family, which incorporate m6A-modified mRNAs into pathways of RNA metabolism. Here, we show that the m6A-binding protein YTHDC1 mediates export of methylated mRNA from the nucleus to the cytoplasm in HeLa cells. Knockdown of YTHDC1 results in an extended residence time for nuclear m6A-containing mRNA, with an accumulation of transcripts in the nucleus and accompanying depletion within the cytoplasm. YTHDC1 interacts with the splicing factor and nuclear export adaptor protein SRSF3, and facilitates RNA binding to both SRSF3 and NXF1. This role for YTHDC1 expands the potential utility of chemical modification of mRNA, and supports an emerging paradigm of m6A as a distinct biochemical entity for selective processing and metabolism of mammalian mRNAs.

1 July 2017 in Cell
Verified
Journal Article
Closed access
YKYuwen Ke
Yuwen Ke
YXYanan Xu
Yanan Xu
XCXuepeng Chen
Xuepeng Chen
SFSongjie Feng
Songjie Feng
ZLZhenbo Liu
Zhenbo Liu
JLJiang Liu
Jiang Liu

28 January 2016 in Scientific Reports
Verified
Journal Article
Open access
SSShu Su
Shu Su
BHBian Hu
Bian Hu
JSJie Shao
Jie Shao
BSBin Shen
Bin Shen
JDJuan Du
Juan Du
BLBaorui Liu
Baorui Liu
Strategies that enhance the function of T cells are critical for immunotherapy. One negative regulator of T-cell activity is ligand PD-L1, which is expressed on dentritic cells (DCs) or some tumor cells and functions through binding of programmed death-1 (PD-1) receptor on activated T cells. Here we described for the first time a non-viral mediated approach to reprogram primary human T cells by disruption of PD-1. We showed that the gene knockout of PD-1 by electroporation of plasmids encoding sgRNA and Cas9 was technically feasible. The disruption of inhibitory checkpoint gene PD-1 resulted in significant reduction of PD-1 expression but didn’t affect the viability of primary human T cells during the prolongedin vitroculture. Cellular immune response of the gene modified T cells was characterized by up-regulated IFN-γ production and enhanced cytotoxicity. These results suggest that we have demonstrated an approach for efficient checkpoint inhibitor disruption in T cells, providing a new strategy for targeting checkpoint inhibitors, which could potentialy be useful to improve the efficacy of T-cell based adoptive therapies.

24 March 2022 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
YZYuan Zong
Yuan Zong
YLYijing Liu
Yijing Liu
CXChenxiao Xue
Chenxiao Xue
BLBoshu Li
Boshu Li
XLXiangyang Li
Xiangyang Li
CGCaixia Gao
Caixia Gao

28 April 2020 in Cell Discovery
Verified
Journal Article
Open access
PDF file
YLYao Liu
Yao Liu
XLXiangyang Li
Xiangyang Li
SHSiting He
Siting He
SHShuhong Huang
Shuhong Huang
CLChao Li
Chao Li
XWXiaolong Wang
Xiaolong Wang

1 September 2020 in Science Bulletin
Verified
Journal Article
Closed access
XWXinjie Wang
Xinjie Wang
MZMingtian Zhong
Mingtian Zhong
YLYong Liu
Yong Liu
PMPeixiang Ma
Peixiang Ma
LDLu Dang
Lu Dang
MLMing Liu
Ming Liu